VW
GILD icon

Vantus Wealth’s Gilead Sciences GILD Stock Holding History

Vantus Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
+2,852
New +$376K 0.19% 143
2025
Q4 		$294K Buy
+2,399
New +$292K 0.22% 149

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vantus Wealth's GILD Position: Q2 2026 in Review

Vantus Wealth opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,852 shares worth $360K. The stake represents 0.19% of the portfolio and ranks #143 among its holdings. This is a return to the name: Vantus Wealth previously reported a position in GILD as recently as Q4 2025.

Vantus Wealth first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,271 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vantus Wealth held 2,852 shares of Gilead Sciences worth $360K as of Q2 2026.
  • Gilead Sciences was a new Vantus Wealth position in Q2 2026.
  • Gilead Sciences made up 0.19% of Vantus Wealth's portfolio in Q2 2026, its #143 holding.
  • Vantus Wealth first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,271 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vantus Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.